For the
quarter ending Dec 2021, consolidated Net sales (including other operating income) of Apollo Hospitals Enterprise has increased 31.85% to Rs 3638.93 crore compared to quarter ended Dec 2020
Operating profit margin has jumped from 14.14% to 16.13%, leading to 50.41% rise in operating profit to Rs 587.02 crore. Raw material cost as a % of total sales (net of stock adjustments) increased from 16.59% to 17.04%. Purchase of finished goods cost fell from 37.37% to 33.30%. Employee cost decreased from 12.74% to 12.03%. Other expenses rose from 19.19% to 21.58%. Other income rose 211.82% to Rs 17.15 crore. PBIDT rose 52.65% to Rs 604.17 crore. Provision for interest fell 7.23% to Rs 93.67 crore. PBDT rose 73.16% to Rs 510.5 crore. Provision for depreciation rose 19.17% to Rs 148.99 crore. Profit before tax grew 112.90% to Rs 361.51 crore. Share of profit/loss was 61.65% lower at Rs 5.96 crore. Provision for tax was expense of Rs 124.22 crore, compared to Rs 51.18 crore. Effective tax rate was 33.80% compared to 27.61%. Minority interest increased 298.93% to Rs 14.88 crore. Net profit attributable to owners of the company increased 75.09% to Rs 228.37 crore. Promoters’ stake was 29.33% as of 31 December 2021 ,compared to 30.82% as of 31 December 2020 . Promoters pledged stake was 22.32% as of 31 December 2021 ,compared to 30.14% as of 31 December 2020 .
For year-to-date (YTD) results analysis.
Net sales (including other operating income) of Apollo Hospitals Enterprise has increased 44.52% to Rs 11116.21 crore. Operating profit margin has jumped from 9.43% to 15.49%, leading to 137.31% rise in operating profit to Rs 1,721.88 crore. Raw material cost as a % of total sales (net of stock adjustments) increased from 14.95% to 18.93%. Purchase of finished goods cost fell from 40.49% to 33.14%. Employee cost decreased from 15.51% to 11.98%. Other expenses rose from 19.76% to 20.54%. Other income rose 93.24% to Rs 47.42 crore. PBIDT rose 135.87% to Rs 1769.3 crore. Provision for interest fell 19.08% to Rs 283.74 crore. PBDT rose 271.89% to Rs 1485.56 crore. Provision for depreciation fell 0.08% to Rs 434.3 crore. Profit before tax reported profit of Rs 1,051.26 crore compared to loss of Rs 35.19 crore. Extraordinary items were increased to Rs 294.11 crore. Provision for tax was expense of Rs 338.35 crore, compared to Rs 17.03 crore. Effective tax rate was 25.07% compared to negative 105.78%.Promoters’ stake was 29.33% as of 31 December 2021 ,compared to 30.82% as of 31 December 2020 . Promoters pledged stake was 22.32% as of 31 December 2021 ,compared to 30.14% as of 31 December 2020 .
Full year results analysis.
Net sales (including other operating income) of Apollo Hospitals Enterprise has declined 6.11% to Rs 10560.01 crore. Sales of Healthcare Services segment has gone down 12.65% to Rs 5,023.02 crore (accounting for 47.45% of total sales). Sales of Retail Pharmacy segment has gone down 52.91% to Rs 2,269.84 crore (accounting for 21.44% of total sales). Sales of Clinics segment fell 2.09% to Rs 681.78 crore (accounting for 6.44% of total sales). Sales of others segment has gone down 4.35% to Rs 4.18 crore (accounting for 0.04% of total sales). Inter-segment sales rose Rs 24.94 crore to Rs 25.01 crore. Profit before interest, tax and other unallocable items (PBIT) has slumped 41.68% to Rs 564.28 crore. PBIT of Healthcare Services segment fell 59.03% to Rs 287.77 crore (accounting for 51.00% of total PBIT). PBIT of Retail Pharmacy segment fell 48.56% to Rs 149.26 crore (accounting for 26.45% of total PBIT). PBIT of Clinics segment rose 51.10% to Rs -10.69 crore (accounting for -1.89% of total PBIT). PBIT of others segment fell 2.86% to Rs -3.24 crore (accounting for -0.57% of total PBIT). PBIT margin of Healthcare Services segment fell from 12.22% to 5.73%. PBIT margin of Retail Pharmacy segment rose from 6.02% to 6.58%. PBIT margin of Clinics segment rose from negative 3.14% to negative 1.57%. PBIT margin of others segment fell from negative 72.08% to negative 77.51%. Overall PBIT margin fell from 8.58% to 5.33%. Operating profit margin has declined from 14.11% to 10.77%, leading to 28.34% decline in operating profit to Rs 1,137.41 crore. Raw material cost as a % of total sales (net of stock adjustments) decreased from 15.93% to 15.19%. Purchase of finished goods cost rose from 33.44% to 39.18%. Employee cost decreased from 16.32% to 14.98%. Other expenses fell from 20.33% to 20.00%. Other income rose 66.81% to Rs 44.99 crore. PBIDT fell 26.75% to Rs 1182.4 crore. Provision for interest fell 15.68% to Rs 449.22 crore. Loan funds rose to Rs 4,159.92 crore as of 31 March 2021 from Rs 3,279.47 crore as of 31 March 2020. Inventories declined from Rs 737.83 crore as of 31 March 2020 to Rs 249.48 crore as of 31 March 2021. Sundry debtors were higher at Rs 1,331.17 crore as of 31 March 2021 compared to Rs 1,027.24 crore as of 31 March 2020. Cash and bank balance rose to Rs 724.40 crore as of 31 March 2021 from Rs 466.75 crore as of 31 March 2020. Investments rose to Rs 1,342.56 crore as of 31 March 2021 from Rs 434.01 crore as of 31 March 2020 . PBDT fell 32.21% to Rs 733.18 crore. Provision for depreciation fell 7.51% to Rs 573.13 crore. Fixed assets declined from Rs 7,321.60 crore as of 31 March 2020 to Rs 6,636.87 crore as of 31 March 2021. Intangible assets increased from Rs 346.21 crore to Rs 375.32 crore. Profit before tax down 65.34% to Rs 160.05 crore. Extraordinary items were decreased to Rs 60.65 crore. Provision for tax was expense of Rs 84.7 crore, compared to Rs 225.19 crore. Effective tax rate was 38.24% compared to 34.28%. Minority interest increased 41.27% to Rs -13.59 crore. Net profit attributable to owners of the company decreased 66.95% to Rs 150.36 crore. Equity capital increased from Rs 69.56 crore as of 31 March 2020 to Rs 71.89 crore as of 31 March 2021. Per share face Value remained same at Rs 5.00. Promoters’ stake was 29.82% as of 31 March 2021 ,compared to 30.81% as of 31 March 2020 . Promoters pledged stake was 27.94% as of 31 March 2021 ,compared to 36.66% as of 31 March 2020 . Cash flow from operating activities decreased to Rs 1,273.48 crore for year ended March 2021 from Rs 1,292.84 crore for year ended March 2020. Cash flow used in acquiring fixed assets during the year ended March 2021 stood at Rs 295.49 crore, compared to Rs 512.98 crore during the year ended March 2020.
| Apollo Hospitals Enterprise : Consolidated Results | | | Quarter ended | Year to Date | Year ended |
|---|
| Particulars | 202112 | 202012 | Var.(%) | 202112 | 202012 | Var.(%) | 202103 | 202003 | Var.(%) |
|---|
| Net Sales (including other operating income) | 3,638.93 | 2,759.85 | 31.85 | 11,116.21 | 7,692.06 | 44.52 | 10,560.01 | 11,246.80 | -6.11 | | OPM (%) | 16.13 | 14.14 | 199 bps | 15.49 | 9.43 | 606 bps | 10.77 | 14.11 | -334 bps | | OP | 587.02 | 390.29 | 50.41 | 1,721.88 | 725.58 | 137.31 | 1,137.41 | 1,587.29 | -28.34 | | Other Inc. | 17.15 | 5.50 | 211.82 | 47.42 | 24.54 | 93.24 | 44.99 | 26.97 | 66.81 | | PBIDT | 604.17 | 395.79 | 52.65 | 1,769.30 | 750.12 | 135.87 | 1,182.40 | 1,614.26 | -26.75 | | Interest | 93.67 | 100.97 | -7.23 | 283.74 | 350.66 | -19.08 | 449.22 | 532.77 | -15.68 | | PBDT | 510.50 | 294.82 | 73.16 | 1,485.56 | 399.46 | 271.89 | 733.18 | 1,081.49 | -32.21 | | Depreciation | 148.99 | 125.02 | 19.17 | 434.3 | 434.65 | -0.08 | 573.13 | 619.69 | -7.51 | | PBT | 361.51 | 169.80 | 112.90 | 1051.26 | -35.19 | LP | 160.05 | 461.8 | -65.34 | | Share of Profit/(Loss) from Associates | 5.96 | 15.54 | -61.65 | 4.33 | -16.35 | LP | 0.77 | -3.11 | LP | | PBT before EO | 367.47 | 185.34 | 98.27 | 1055.59 | -51.54 | LP | 160.82 | 458.69 | -64.94 | | EO Income | 0 | 0 | - | 294.11 | 35.44 | 729.88 | 60.65 | 198.3 | -69.42 | | PBT after EO | 367.47 | 185.34 | 98.27 | 1349.7 | -16.1 | LP | 221.47 | 656.99 | -66.29 | | Taxation | 124.22 | 51.18 | 142.71 | 338.35 | 17.03 | 1,886.79 | 84.7 | 225.19 | -62.39 | | PAT | 243.25 | 134.16 | 81.31 | 1011.35 | -33.13 | LP | 136.77 | 431.8 | -68.33 | | Minority Interest (MI) | 14.88 | 3.73 | 298.93 | 45.88 | -15.64 | PL | -13.59 | -23.14 | 41.27 | | Net profit | 228.37 | 130.43 | 75.09 | 965.47 | -17.49 | LP | 150.36 | 454.94 | -66.95 | | P/(L) from discontinued operations net of tax | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | | Net profit after discontinued operations | 228.37 | 130.43 | 75.09 | 965.47 | -17.49 | LP | 150.36 | 454.94 | -66.95 | | EPS (Rs)* | 15.88 | 9.07 | 75.09 | 52.53 | -1.30 | LP | 7.60 | 22.07 | -65.57 | | | * EPS is on current equity of Rs 71.89 crore, Face value of Rs 5, Excluding extraordinary items. | | # EPS is not annualised | | bps : Basis points | | EO : Extraordinary items | | Figures in Rs crore | | Source: Capitaline Corporate Database |
|
|